These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30301369)

  • 1. GZD2202, a novel TrkB inhibitor, suppresses BDNF-mediated proliferation and metastasis in neuroblastoma models.
    Zou J; Zhang Z; Xu F; Cui S; Qi C; Luo J; Wang Z; Lu X; Tu Z; Ren X; Song L; Ding K
    J Drug Target; 2019 Apr; 27(4):442-450. PubMed ID: 30301369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The selective Trk inhibitor AZ623 inhibits brain-derived neurotrophic factor-mediated neuroblastoma cell proliferation and signaling and is synergistic with topotecan.
    Zage PE; Graham TC; Zeng L; Fang W; Pien C; Thress K; Omer C; Brown JL; Zweidler-McKay PA
    Cancer; 2011 Mar; 117(6):1321-91. PubMed ID: 20960503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3'-kinase pathway.
    Jaboin J; Kim CJ; Kaplan DR; Thiele CJ
    Cancer Res; 2002 Nov; 62(22):6756-63. PubMed ID: 12438277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trk inhibitor attenuates the BDNF/TrkB-induced protection of neuroblastoma cells from etoposide in vitro and in vivo.
    Li Z; Zhang Y; Tong Y; Tong J; Thiele CJ
    Cancer Biol Ther; 2015; 16(3):477-83. PubMed ID: 25700942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of choriocarcinoma invasion and metastasis following blockade of BDNF/TrkB signaling.
    Kawamura K; Kawamura N; Okamoto N; Manabe M
    Cancer Med; 2013 Dec; 2(6):849-61. PubMed ID: 24403258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TrkB inhibition by GNF-4256 slows growth and enhances chemotherapeutic efficacy in neuroblastoma xenografts.
    Croucher JL; Iyer R; Li N; Molteni V; Loren J; Gordon WP; Tuntland T; Liu B; Brodeur GM
    Cancer Chemother Pharmacol; 2015 Jan; 75(1):131-41. PubMed ID: 25394774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blocking TrkB-BDNF signal pathway decreases the livability of neuroblastoma cells].
    Zhang JH; Li AM; Chen S; Tong HX; Zhang KR; Zhang JH
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):47-50. PubMed ID: 18289471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain-derived neurotrophic factor/tropomyosin-related kinase B signaling pathway contributes to the aggressive behavior of lung squamous cell carcinoma.
    Ozono K; Ohishi Y; Onishi H; Nakamura K; Motoshita J; Kato M; Nakanishi R; Nakamura M; Oda Y
    Lab Invest; 2017 Nov; 97(11):1332-1342. PubMed ID: 28604655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.
    Eggert A; Ikegaki N; Liu XG; Brodeur GM
    Klin Padiatr; 2000; 212(4):200-5. PubMed ID: 10994551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of CEP-751 (KT-6587) on neuroblastoma xenografts expressing TrkB.
    Evans AE; Kisselbach KD; Liu X; Eggert A; Ikegaki N; Camoratto AM; Dionne C; Brodeur GM
    Med Pediatr Oncol; 2001 Jan; 36(1):181-4. PubMed ID: 11464878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness.
    Cimmino F; Schulte JH; Zollo M; Koster J; Versteeg R; Iolascon A; Eggert A; Schramm A
    Oncogene; 2009 May; 28(19):2015-23. PubMed ID: 19363525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of 3-(imidazo[1,2-a]pyrazin-3-ylethynyl)-2-methylbenzamides as potent and selective pan-tropomyosin receptor kinase (TRK) inhibitors.
    Cui S; Wang Y; Wang Y; Tang X; Ren X; Zhang L; Xu Y; Zhang Z; Zhang ZM; Lu X; Ding K
    Eur J Med Chem; 2019 Oct; 179():470-482. PubMed ID: 31271959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrkB rescue of neuroblastoma cells from chemotherapy-induced cell death.
    Li Z; Jaboin J; Dennis PA; Thiele CJ
    Cancer Res; 2005 Mar; 65(6):2070-5. PubMed ID: 15781614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse model.
    Iyer R; Wehrmann L; Golden RL; Naraparaju K; Croucher JL; MacFarland SP; Guan P; Kolla V; Wei G; Cam N; Li G; Hornby Z; Brodeur GM
    Cancer Lett; 2016 Mar; 372(2):179-86. PubMed ID: 26797418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of tyrosine kinase receptor B and brain-derived neurotrophic factor on chemoresistance in neuroblastoma].
    Li AM; Zhang JH; Zhang JH; Zhang KR; Rong DJ
    Zhonghua Er Ke Za Zhi; 2006 Jul; 44(7):535-9. PubMed ID: 17044982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain-derived neurotrophic factor (BDNF)-induced tropomyosin-related kinase B (Trk B) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer.
    Tanaka K; Okugawa Y; Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Araki T; Uchida K; Mohri Y; Kusunoki M
    PLoS One; 2014; 9(5):e96410. PubMed ID: 24801982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells.
    Matsumoto K; Wada RK; Yamashiro JM; Kaplan DR; Thiele CJ
    Cancer Res; 1995 Apr; 55(8):1798-806. PubMed ID: 7712490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of TrkB Expression and Signaling by Valproic Acid and Other Histone Deacetylase Inhibitors.
    Dedoni S; Marras L; Olianas MC; Ingianni A; Onali P
    J Pharmacol Exp Ther; 2019 Sep; 370(3):490-503. PubMed ID: 31308194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotine regulates SH-SY5Y neuroblastoma cell proliferation through the release of brain-derived neurotrophic factor.
    Serres F; Carney SL
    Brain Res; 2006 Jul; 1101(1):36-42. PubMed ID: 16790237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of brain-derived neurotrophic factor/tyrosine kinase B signaling suppresses choriocarcinoma cell growth.
    Kawamura N; Kawamura K; Manabe M; Tanaka T
    Endocrinology; 2010 Jul; 151(7):3006-14. PubMed ID: 20463055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.